182 related articles for article (PubMed ID: 3388291)
1. Detection and quantitation of cleaved and uncleaved high molecular weight kininogen in plasma by ligand blotting with radiolabeled plasma prekallikrein or factor XI.
Lämmle B; Zuraw BL; Heeb MJ; Schwarz HP; Berrettini M; Curd JG; Griffin JH
Thromb Haemost; 1988 Apr; 59(2):151-61. PubMed ID: 3388291
[TBL] [Abstract][Full Text] [Related]
2. Cleavage of human high molecular weight kininogen markedly enhances its coagulant activity. Evidence that this molecule exists as a procofactor.
Scott CF; Silver LD; Schapira M; Colman RW
J Clin Invest; 1984 Apr; 73(4):954-62. PubMed ID: 6561202
[TBL] [Abstract][Full Text] [Related]
3. Purification of high molecular weight kininogen and the role of this agent in blood coagulation.
Saito H
J Clin Invest; 1977 Sep; 60(3):584-94. PubMed ID: 893664
[TBL] [Abstract][Full Text] [Related]
4. Immunoblotting studies of coagulation factor XII, plasma prekallikrein, and high molecular weight kininogen.
Lämmle B; Berrettini M; Griffin JH
Semin Thromb Hemost; 1987 Jan; 13(1):106-14. PubMed ID: 3494310
[TBL] [Abstract][Full Text] [Related]
5. Activation and function of human Hageman factor. The role of high molecular weight kininogen and prekallikrein.
Meier HL; Pierce JV; Colman RW; Kaplan AP
J Clin Invest; 1977 Jul; 60(1):18-31. PubMed ID: 874082
[TBL] [Abstract][Full Text] [Related]
6. Potentiation of the function of Hageman factor fragments by high molecular weight kininogen.
Liu CY; Scott CF; Bagdasarian A; Pierce JV; Kaplan AP; Colman RW
J Clin Invest; 1977 Jul; 60(1):7-17. PubMed ID: 874091
[TBL] [Abstract][Full Text] [Related]
7. Hageman factor-dependent pathways: mechanism of initiation and bradykinin formation.
Kaplan AP
Fed Proc; 1983 Nov; 42(14):3123-7. PubMed ID: 6556144
[TBL] [Abstract][Full Text] [Related]
8. Association of factor XI and high molecular weight kininogen in human plasma.
Thompson RE; Mandle R; Kaplan AP
J Clin Invest; 1977 Dec; 60(6):1376-80. PubMed ID: 915004
[TBL] [Abstract][Full Text] [Related]
9. Studies of binding of prekallikrein and Factor XI to high molecular weight kininogen and its light chain.
Thompson RE; Mandle R; Kaplan AP
Proc Natl Acad Sci U S A; 1979 Oct; 76(10):4862-6. PubMed ID: 291905
[TBL] [Abstract][Full Text] [Related]
10. Function and immunochemistry of prekallikrein-high molecular weight kininogen complex in plasma.
Scott CF; Colman RW
J Clin Invest; 1980 Feb; 65(2):413-21. PubMed ID: 7356688
[TBL] [Abstract][Full Text] [Related]
11. Prekallikrein activation and high-molecular-weight kininogen consumption in hereditary angioedema.
Schapira M; Silver LD; Scott CF; Schmaier AH; Prograis LJ; Curd JG; Colman RW
N Engl J Med; 1983 May; 308(18):1050-3. PubMed ID: 6601240
[TBL] [Abstract][Full Text] [Related]
12. Chloroform-induced fibrinolysis. Its dependence on Hageman factor, plasma prekallikrein, and high molecular weight kininogen.
Gordon EM; Ratnoff OD; Goldsmith GH
J Lab Clin Med; 1980 Apr; 95(4):507-14. PubMed ID: 7359011
[TBL] [Abstract][Full Text] [Related]
13. Interactions among Hageman factor (HG, Factor XII), plasma thromboplastin antecedent (PTA, Factor XI), plasma prekallikrein (PK, Fletcher factor) and high molecular weight kininogen (HMW-K, Fitzgerald factor) in blood coagulation.
Saito H; Ratnoff OD
Adv Exp Med Biol; 1979; 120B():61-70. PubMed ID: 517254
[TBL] [Abstract][Full Text] [Related]
14. Protein-protein interactions in contact activation of blood coagulation. Binding of high molecular weight kininogen and the 5-(iodoacetamido) fluorescein-labeled kininogen light chain to prekallikrein, kallikrein, and the separated kallikrein heavy and light chains.
Bock PE; Shore JD; Tans G; Griffin JH
J Biol Chem; 1985 Oct; 260(23):12434-43. PubMed ID: 3850090
[TBL] [Abstract][Full Text] [Related]
15. The contact activation mechanism in human plasma: activation induced by dextran sulfate.
van der Graaf F; Keus FJ; Vlooswijk RA; Bouma BN
Blood; 1982 Jun; 59(6):1225-33. PubMed ID: 6177360
[TBL] [Abstract][Full Text] [Related]
16. Generation of plasmin during acute attacks of hereditary angioedema.
Cugno M; Hack CE; de Boer JP; Eerenberg AJ; Agostoni A; Cicardi M
J Lab Clin Med; 1993 Jan; 121(1):38-43. PubMed ID: 8426080
[TBL] [Abstract][Full Text] [Related]
17. Flaujeac factor deficiency. Reconstitution with highly purified bovine high molecular weight-kininogen and delineation of a new permeability-enhancing peptide released by plasma kallikrein from bovine high molecular weight-kininogen.
Matheson RT; Miller DR; Lacombe MJ; Han YN; Iwanaga S; Kato H; wuepper KD
J Clin Invest; 1976 Dec; 58(6):1395-406. PubMed ID: 993350
[TBL] [Abstract][Full Text] [Related]
18. Plasma prekallikrein: quantitative determination by direct activation with Hageman factor fragment (beta-XIIa).
Alving BM; Tankersley DL; Mason BL
J Lab Clin Med; 1983 Feb; 101(2):226-41. PubMed ID: 6549773
[TBL] [Abstract][Full Text] [Related]
19. Radioimmunoassay of human high molecular weight kininogen in normal and deficient plasmas.
Proud D; Pierce JV; Pisano JJ
J Lab Clin Med; 1980 Apr; 95(4):563-74. PubMed ID: 6153694
[TBL] [Abstract][Full Text] [Related]
20. Role of HMW kininogen in surface-mediated activation of Factor XII.
Shimada T; Sugo T; Kato H; Iwanaga S
Adv Exp Med Biol; 1983; 156():73-85. PubMed ID: 6134440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
